Oral and gingival health research

Gingival overgrowth is an abnormal enlargement of the gum tissue that can arise as a side effect of certain medications — including the immunosuppressants cyclosporin A and tacrolimus widely used in organ transplantation — or through rare inherited conditions such as hereditary gingival fibromatosis. Researchers in this area investigate the cellular and molecular mechanisms driving excess connective tissue accumulation, with particular attention to how drugs disrupt collagen metabolism, alter matrix metalloproteinase activity, and trigger signaling molecules like connective tissue growth factor. Understanding these pathways matters because gingival overgrowth can impair oral hygiene, cause pain, and affect quality of life in patients already managing complex medical conditions. Key open questions include why only a subset of patients on the same drug develop severe overgrowth, and whether identifying genetic or biochemical susceptibility markers could guide clinicians toward safer drug substitutions or targeted therapies before tissue changes become irreversible.

Works

40,887

Total citations

196,098

Keywords

Gingival OvergrowthDrug-InducedHereditary Gingival FibromatosisCyclosporin ATacrolimusCollagen Metabolism